{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:44:28Z","timestamp":1792687468726,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","funder":[{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo state Research Foundation FAPESP Brazil","doi-asserted-by":"publisher","award":["2015\/10356-2"],"award-info":[{"award-number":["2015\/10356-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Brazilian National Council for Research and Development","doi-asserted-by":"publisher","award":["421299\/2018-5"],"award-info":[{"award-number":["421299\/2018-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Brazilian National Council for Research and Development","doi-asserted-by":"publisher","award":["304797\/2019-7"],"award-info":[{"award-number":["304797\/2019-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Valproic acid\/sodium valproate (VPA), a well-known anti-epileptic agent, in-hibits histone deacetylases, induces histone hyperacetylation, promotes DNA demethylation, and affects the histone methylation status in some cell models. Histone methylation profiles have been described as potential markers for cervical cancer prognosis. However, histone methylation markers that can be studied in a cervical cancer cell line, like HeLa cells, have not been investigated following treatment with VPA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method:<\/jats:title><jats:p>In this study, the effect of 0.5 mM and 2.0 mM VPA for 24 h on H3K4me2\/me3, H3K9me\/me2 and H3K27me\/me3 signals as well as on KMT2D, EZH2, and KDM3A gene expression was investigated using confocal microscopy, Western blotting, and RT-PCR. Histone methylation changes were also in-vestigated by Fourier-transform infrared spectroscopy (FTIR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Result:<\/jats:title><jats:p>We found that VPA induces increased levels of H3K4me2\/me3 and H3K9me, which are indic-ative of chromatin activation. Particularly, H3K4me2 markers appeared intensified close to the nuclear periphery, which may suggest their implication in increased transcriptional memory. The abundance of H3K4me2\/me3 in the presence of VPA was associated with increased methyltransferase KMT2D gene expression. VPA induced hypomethylation of H3K9me2, which is associated with gene silencing, and concomitant with the demethylase KDM3A, it increased gene expression. Although VPA induces in-creased H3K27me\/me3 levels, it is suggested that the role of the methyltransferase EZH2 in this context could be affected by interactions with this drug.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Histone FTIR spectra were not affected by VPA under present experimental conditions. Whether our epigenetic results are consistent with VPA affecting the aggressive tumorous state of HeLa cells, further investigation is required.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1874467215666220316110405","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T11:01:11Z","timestamp":1647514871000},"page":"197-210","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sodium Valproate Modulates the Methylation Status of Lysine Residues 4, 9 and 27 in Histone H3 of HeLa Cells"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1629-5619","authenticated-orcid":true,"given":"Maria Luiza Silveira","family":"Mello","sequence":"first","affiliation":[{"name":"Department of Structural and Functional Biology, Institute of Biology, University of Campinas (Unicamp), 13083-862 Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-3482","authenticated-orcid":true,"given":"Marina Amorim","family":"Rocha","sequence":"additional","affiliation":[{"name":"Department of Structural and Functional Biology, Institute of Biology, University of Campinas (Unicamp), 13083-862 Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0285-1653","authenticated-orcid":true,"given":"Benedicto","family":"de Campos Vidal","sequence":"additional","affiliation":[{"name":"Department of Structural and Functional Biology, Institute of Biology, University of Campinas (Unicamp), 13083-862 Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0920-1211(02)00182-1","volume":"52","author":"Perucca E.","year":"2002","unstructured":"Perucca E.; Overtreatment in epilepsy: Adverse consequences and mechanisms. Epilepsy Res 2002,52(1),25-33","journal-title":"Epilepsy Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"479364","DOI":"10.1155\/2010\/479364","volume":"2010","author":"Chateauvieux S.","year":"2010","unstructured":"Chateauvieux S.; Morceau F.; Dicato M.; Diederich M.; Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol 2010,2010,479364","journal-title":"J Biomed Biotechnol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"G&#xF6;ttlicher M.","year":"2001","unstructured":"G&#xF6;ttlicher M.; Minucci S.; Zhu P.; Kr&#xE4;mer O.H.; Schimpf A.; Giavara S.; Sleeman J.P.; Lo Coco F.; Nervi C.; Pelicci P.G.; Heinzel T.; Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001,20(24),6969-6978","journal-title":"EMBO J"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"Phiel C.J.","year":"2001","unstructured":"Phiel C.J.; Zhang F.; Huang E.Y.; Guenther M.G.; Lazar M.A.; Klein P.S.; Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001,276(39),36734-36741","journal-title":"J Biol Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cnr.2004.09.013","volume":"4","author":"Lagace D.C.","year":"2004","unstructured":"Lagace D.C.; O\u2019Brien W.T.; Gurvich N.; Nachtigal M.W.; Klein P.S.; Valproic acid: How it works. Or not. Clin Neurosci Res 2004,4(3-4),215-225","journal-title":"Clin Neurosci Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.bcp.2005.02.012","volume":"69","author":"Eyal S.","year":"2005","unstructured":"Eyal S.; Yagen B.; Shimshoni J.; Bialer M.; Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives. Biochem Pharmacol 2005,69(10),1501-1508","journal-title":"Biochem Pharmacol"},{"key":"ref=7","first-page":"1000118","volume":"02","author":"Sun L.","year":"2014","unstructured":"Sun L.; Coy D.H.; Anti-convulsant drug valproic acid in cancers and in combination anti-cancer therapeutics. Mod Chem Appl 2014,02,1000118","journal-title":"Mod Chem Appl"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cbi.2017.12.003","volume":"280","author":"Aztopal N.","year":"2018","unstructured":"Aztopal N.; Erkisa M.; Erturk E.; Ulukaya E.; Tokullugil A.H.; Ari F.; Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells. Chem Biol Interact 2018,280,51-58","journal-title":"Chem Biol Interact"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"103797","DOI":"10.1016\/j.bioorg.2020.103797","volume":"99","author":"Ibrahim T.S.","year":"2020","unstructured":"Ibrahim T.S.; Sheha T.A.; Abo-Dya N.E.; AlAwadh M.A.; Alhakamy N.A.; Abdel-Samii Z.K.; Panda S.S.; Abuo-Rahma G.E.A.; Mohamed M.F.A.; Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity. Bioorg Chem 2020,99,103797","journal-title":"Bioorg Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"645518","DOI":"10.3389\/fcell.2021.645518","volume":"9","author":"Mcllo M.L.","year":"2021","unstructured":"Mcllo M.L.; Sodium valproate-induced chromatin remodeling. Front Cell Dev Biol 2021,9,645518","journal-title":"Front Cell Dev Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/med.10017","volume":"22","author":"Blaheta R.A.","year":"2002","unstructured":"Blaheta R.A.; Cinatl J.; Anti-tumor mechanisms of valproate: A novel role for an old drug. Med Res Rev 2002,22(5),492-511","journal-title":"Med Res Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","volume":"85","author":"Das C.M.","year":"2007","unstructured":"Das C.M.; Aguilera D.; Vasquez H.; Prasad P.; Zhang M.; Wolff J.E.; Gopalakrishnan V.; Valproic acid induces p21 and topoisomerase-II (&#x3B1;\/&#x3B2;) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines. J Neurooncol 2007,85(2),159-170","journal-title":"J Neurooncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jb\/mvn074","volume":"144","author":"Sami S.","year":"2008","unstructured":"Sami S.; H&#xF6;ti N.; Xu H.M.; Shen Z.; Huang X.; Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo. J Biochem 2008,144(3),357-362","journal-title":"J Biochem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbrc.2018.11.103","volume":"508","author":"Fang E.","year":"2019","unstructured":"Fang E.; Wang J.; Hong M.; Zheng L.; Tong Q.; Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma. Biochem Biophys Res Commun 2019,508(1),9-16","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1158\/0008-5472.CAN-06-2595","volume":"67","author":"Yang Q.","year":"2007","unstructured":"Yang Q.; Tian Y.; Liu S.; Zeine R.; Chlenski A.; Salwen H.R.; Henkin J.; Cohn S.L.; Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma. Cancer Res 2007,67(4),1716-1724","journal-title":"Cancer Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","volume":"34","author":"Duenas-Gonzalez A.","year":"2008","unstructured":"Duenas-Gonzalez A.; Candelaria M.; Perez-Plascencia C.; Perez-Cardenas E.; de la Cruz-Hernandez E.; Herrera L.A.; Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat Rev 2008,34(3),206-222","journal-title":"Cancer Treat Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.canlet.2009.03.013","volume":"280","author":"Batty N.","year":"2009","unstructured":"Batty N.; Malouf G.G.; Issa J.P.J.; Histone deacetylase inhibitors as anti-neoplastic agents. Cancer Lett 2009,280(2),192-200","journal-title":"Cancer Lett"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"10678","DOI":"10.1074\/jbc.M109.057836","volume":"285","author":"Venkataramani V.","year":"2010","unstructured":"Venkataramani V.; Rossner C.; Iffland L.; Schweyer S.; Tamboli I.Y.; Walter J.; Wirths O.; Bayer T.A.; Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein. J Biol Chem 2010,285(14),10678-10689","journal-title":"J Biol Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2018.07.057","volume":"835","author":"Heers H.","year":"2018","unstructured":"Heers H.; Stanislaw J.; Harrelson J.; Lee M.W.; Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer. Eur J Pharmacol 2018,835,61-74","journal-title":"Eur J Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13578-019-0312-0","volume":"9","author":"Li H.","year":"2019","unstructured":"Li H.; Zhang Z.; Gao C.; Wu S.; Duan Q.; Wu H.; Wang C.; Shen Q.; Yin T.; Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3\/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells. Cell Biosci 2019,9(1),50","journal-title":"Cell Biosci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.21873\/invivo.11445","volume":"33","author":"Tran L.N.","year":"2019","unstructured":"Tran L.N.; Kichenadasse G.; Morel K.L.; Lavranos T.C.; Klebe S.; Lower K.M.; Ormsby R.J.; Elliot D.J.; Sykes P.J.; The combination of metformin and valproic acid has a greater anti-tumoral effect on prostate cancer growth in vivo than either drug alone. IN VIVO (Brooklyn) 2019,33(1),99-108","journal-title":"IN VIVO (Brooklyn)"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/carcin\/bgl167","volume":"28","author":"Milutinovic S.","year":"2007","unstructured":"Milutinovic S.; D\u2019Alessio A.C.; Detich N.; Szyf M.; Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 2007,28(3),560-571","journal-title":"Carcinogenesis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"14639","DOI":"10.1073\/pnas.1008522107","volume":"107","author":"Lee J.H.","year":"2010","unstructured":"Lee J.H.; Choy M.L.; Ngo L.; Foster S.S.; Marks P.A.; Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. Proc Natl Acad Sci USA 2010,107(33),14639-14644","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/npp.2009.188","volume":"35","author":"Perisic T.","year":"2010","unstructured":"Perisic T.; Zimmermann N.; Kirmeier T.; Asmus M.; Tuorto F.; Uhr M.; Holsboer F.; Rein T.; Zschocke J.; Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology 2010,35(3),792-805","journal-title":"Neuropsychopharmacology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e36660","DOI":"10.1371\/journal.pone.0036660","volume":"7","author":"Jiang J.","year":"2012","unstructured":"Jiang J.; Lu J.; Lu D.; Liang Z.; Li L.; Ouyang S.; Kong X.; Jiang H.; Shen B.; Luo C.; Investigation of the acetylation mechanism by GCN5 histone acetyltransferase. PLoS One 2012,7(5),e36660","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e0170740","DOI":"10.1371\/journal.pone.0170740","volume":"12","author":"Veronezi G.M.","year":"2017","unstructured":"Veronezi G.M.; Felisbino M.B.; Gatti M.S.; Mello M.L.; Vidal B.C.; DNA methylation changes in valproic acid-treated HeLa cells as assessed by image analysis, immunofluorescence and vibrational microspectroscopy. PLoS One 2017,12(1),e0170740","journal-title":"PLoS One"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"18236","DOI":"10.1038\/s41598-019-54848-x","volume":"9","author":"Rocha M.A.","year":"2019","unstructured":"Rocha M.A.; Veronezi G.M.; Felisbino M.B.; Gatti M.S.; Tamashiro W.; Mello M.L.; Sodium valproate and 5-aza-2'-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells. Sci Rep 2019,9(1),18236","journal-title":"Sci Rep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1158\/0008-5472.CAN-04-2478","volume":"65","author":"Marchion D.C.","year":"2005","unstructured":"Marchion D.C.; Bicaku E.; Daud A.I.; Sullivan D.M.; Munster P.N.; Valproic acid alters chromatin structure by regulation of chromatin modulation proteins. Cancer Res 2005,65(9),3815-3822","journal-title":"Cancer Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.dnarep.2016.05.013","volume":"44","author":"Schuermann D.","year":"2016","unstructured":"Schuermann D.; Weber A.R.; Sch&#xE4;r P.; Active DNA demethylation by DNA repair: Facts and uncertainties. DNA Repair 2016,44,92-102","journal-title":"DNA Repair"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nature09303","volume":"466","author":"Ito S.","year":"2010","unstructured":"Ito S.; D\u2019Alessio A.C.; Taranova O.V.; Hong K.; Sowers L.C.; Zhang Y.; Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010,466(7310),1129-1133","journal-title":"Nature"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature12362","volume":"500","author":"Blaschke K.","year":"2013","unstructured":"Blaschke K.; Ebata K.T.; Karimi M.M.; Zepeda-Mart&#xED;nez J.A.; Goyal P.; Mahapatra S.; Tam A.; Laird D.J.; Hirst M.; Rao A.; Lorincz M.C.; Ramalho-Santos M.; Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 2013,500(7461),222-226","journal-title":"Nature"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrm3589","volume":"14","author":"Pastor W.A.","year":"2013","unstructured":"Pastor W.A.; Aravind L.; Rao A.; TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol 2013,14(6),341-356","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.exer.2014.01.021","volume":"121","author":"Palsamy P.","year":"2014","unstructured":"Palsamy P.; Bidasee K.R.; Shinohara T.; Valproic acid suppresses Nrf2\/Keap1 dependent antioxidant protection through induction of endoplasmic reticulum stress and Keap1 promoter DNA demethylation in human lens epithelial cells. Exp Eye Res 2014,121,26-34","journal-title":"Exp Eye Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/msb.134974","volume":"10","author":"Lanouette S.","year":"2014","unstructured":"Lanouette S.; Mongeon V.; Figeys D.; Couture J.F.; The functional diversity of protein lysine methylation. Mol Syst Biol 2014,10(4),724","journal-title":"Mol Syst Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrg3173","volume":"13","author":"Greer E.L.","year":"2012","unstructured":"Greer E.L.; Shi Y.; Histone methylation: A dynamic mark in health, disease and inheritance. Nat Rev Genet 2012,13(5),343-357","journal-title":"Nat Rev Genet"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ng1966","volume":"39","author":"Heintzman N.D.","year":"2007","unstructured":"Heintzman N.D.; Stuart R.K.; Hon G.; Fu Y.; Ching C.W.; Hawkins R.D.; Barrera L.O.; Van Calcar S.; Qu C.; Ching K.A.; Wang W.; Weng Z.; Green R.D.; Crawford G.E.; Ren B.; Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007,39(3),311-318","journal-title":"Nat Genet"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1101\/gr.5767907","volume":"17","author":"Roh T.Y.","year":"2007","unstructured":"Roh T.Y.; Wei G.; Farrell C.M.; Zhao K.; Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns. Genome Res 2007,17(1),74-81","journal-title":"Genome Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2006.07.009","volume":"89","author":"V&#xF6;lkel P.","year":"2007","unstructured":"V&#xF6;lkel P.; Angrand P.O.; The control of histone lysine methylation in epigenetic regulation. Biochimie 2007,89(1),1-20","journal-title":"Biochimie"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1074\/jbc.M114.627646","volume":"290","author":"Shinsky S.A.","year":"2015","unstructured":"Shinsky S.A.; Monteith K.E.; Viggiano S.; Cosgrove M.S.; Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation. J Biol Chem 2015,290(10),6361-6375","journal-title":"J Biol Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1073\/pnas.082249499","volume":"99","author":"Bernstein B.E.","year":"2002","unstructured":"Bernstein B.E.; Humphrey E.L.; Erlich R.L.; Schneider R.; Bouman P.; Liu J.S.; Kouzarides T.; Schreiber S.L.; Methylation of histone H3 Lys 4 in coding regions of active genes. Proc Natl Acad Sci 2002,99(13),8695-8700","journal-title":"Proc Natl Acad Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2005.01.001","volume":"120","author":"Bernstein B.E.","year":"2005","unstructured":"Bernstein B.E.; Kamal M.; Lindblad-Toh K.; Bekiranov S.; Bailey D.K.; Huebert D.J.; McMahon S.; Karlsson E.K.; Kulbokas E.J.; Gingeras T.R.; Schreiber S.L.; Lander E.S.; Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005,120(2),169-181","journal-title":"Cell"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature01080","volume":"419","author":"Santos-Rosa H.","year":"2002","unstructured":"Santos-Rosa H.; Schneider R.; Bannister A.J.; Sherriff J.; Bernstein B.E.; Emre N.C.T.; Schreiber S.L.; Mellor J.; Kouzarides T.; Active genes are tri-methylated at K4 of histone H3. Nature 2002,419(6905),407-411","journal-title":"Nature"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","volume":"129","author":"Barski A.","year":"2007","unstructured":"Barski A.; Cuddapah S.; Cui K.; Roh T.Y.; Schones D.E.; Wang Z.; Wei G.; Chepelev I.; Zhao K.; High-resolution profiling of histone methylations in the human genome. Cell 2007,129(4),823-837","journal-title":"Cell"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1038\/emm.2017.11","volume":"49","author":"Hyun K.","year":"2017","unstructured":"Hyun K.; Jeon J.; Park K.; Kim J.; Writing, erasing and reading histone lysine methylations. Exp Mol Med 2017,49(4),e324","journal-title":"Exp Mol Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00018-017-2596-8","volume":"75","author":"Pan M.R.","year":"2018","unstructured":"Pan M.R.; Hsu M.C.; Chen L.T.; Hung W.C.; Orchestration of H3K27 methylation: Mechanisms and therapeutic implication. Cell Mol Life Sci 2018,75(2),209-223","journal-title":"Cell Mol Life Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.tibs.2013.09.004","volume":"38","author":"Herz H.M.","year":"2013","unstructured":"Herz H.M.; Garruss A.; Shilatifard A.; SET for life: Biochemical activities and biological functions of SET domain-containing proteins. Trends Biochem Sci 2013,38(12),621-639","journal-title":"Trends Biochem Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1093\/nar\/gkr416","volume":"39","author":"Young M.D.","year":"2011","unstructured":"Young M.D.; Willson T.A.; Wakefield M.J.; Trounson E.; Hilton D.J.; Blewitt M.E.; Oshlack A.; Majewski I.J.; ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity. Nucleic Acids Res 2011,39(17),7415-7427","journal-title":"Nucleic Acids Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1074\/jbc.M606773200","volume":"282","author":"Nightingale K.P.","year":"2007","unstructured":"Nightingale K.P.; Gendreizig S.; White D.A.; Bradbury C.; Hollfelder F.; Turner B.M.; Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem 2007,282(7),4408-4416","journal-title":"J Biol Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.taap.2010.08.001","volume":"248","author":"Tung E.W.","year":"2010","unstructured":"Tung E.W.; Winn L.M.; Epigenetic modifications in valproic acid-induced teratogenesis. Toxicol Appl Pharmacol 2010,248(3),201-209","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.neuropharm.2010.09.022","volume":"60","author":"Marinova Z.","year":"2011","unstructured":"Marinova Z.; Leng Y.; Leeds P.; Chuang D.M.; Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons. Neuropharmacology 2011,60(7-8),1109-1115","journal-title":"Neuropharmacology"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1756-8935-6-11","volume":"6","author":"Boudadi E.","year":"2013","unstructured":"Boudadi E.; Stower H.; Halsall J.A.; Rutledge C.E.; Leeb M.; Wutz A.; O\u2019Neill L.P.; Nightingale K.P.; Turner B.M.; The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing. Epigenetics Chromatin 2013,6(1),11","journal-title":"Epigenetics Chromatin"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/07391102.2014.938247","volume":"33","author":"Ganai S.A.","year":"2015","unstructured":"Ganai S.A.; Kalladi S.M.; Mahadevan V.; HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells. J Biomol Struct Dyn 2015,33(6),1185-1197","journal-title":"J Biomol Struct Dyn"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1073\/pnas.1009933108","volume":"108","author":"McLaughlin-Drubin M.E.","year":"2011","unstructured":"McLaughlin-Drubin M.E.; Crum C.P.; M&#xFC;nger K.; Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci 2011,108(5),2130-2135","journal-title":"Proc Natl Acad Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/ijms18030477","volume":"18","author":"Beyer S.","year":"2017","unstructured":"Beyer S.; Zhu J.; Mayr D.; Kuhn C.; Schulze S.; Hofmann S.; Dannecker C.; Jeschke U.; Kost B.P.; Histone H3 acetyl K9 and histone H3 tri methyl K4 as prognostic markers for patients with cervical cancer. Int J Mol Sci 2017,18(3),477","journal-title":"Int J Mol Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3892\/or.2013.2747","volume":"30","author":"Han B.R.","year":"2013","unstructured":"Han B.R.; You B.R.; Park W.H.; Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis. Oncol Rep 2013,30(6),2999-3005","journal-title":"Oncol Rep"},{"key":"ref=56","first-page":"3944","volume":"15","author":"Li X.M.","year":"2018","unstructured":"Li X.M.; Luo X.G.; He J.F.; Wang N.; Zhou H.; Yang P.L.; Zhang T.C.; Induction of apoptosis in human cervical carcinoma HeLa cells by active compounds from Hypericum ascyron L. Oncol Lett 2018,15(3),3944-3950","journal-title":"Oncol Lett"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1476-4598-7-70","volume":"7","author":"Dejligbjerg M.","year":"2008","unstructured":"Dejligbjerg M.; Grauslund M.; Litman T.; Collins L.; Qian X.; Jeffers M.; Lichenstein H.; Jensen P.B.; Sehested M.; Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells. Mol Cancer 2008,7(1),70","journal-title":"Mol Cancer"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"e29144","DOI":"10.1371\/journal.pone.0029144","volume":"6","author":"Felisbino M.B.","year":"2011","unstructured":"Felisbino M.B.; Tamashiro W.; Mello M.L.; Chromatin remodeling, cell proliferation and cell death in valproic acid-treated HeLa cells. PLoS One 2011,6(12),e29144","journal-title":"PLoS One"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ijbiomac.2017.02.098","volume":"99","author":"Sargolzaei J.","year":"2017","unstructured":"Sargolzaei J.; Rabbani-Chadegani A.; Mollaei H.; Deezagi A.; Spectroscopic analysis of the interaction of valproic acid with histone H1 in solution and in chromatin structure. Int J Biol Macromol 2017,99,427-432","journal-title":"Int J Biol Macromol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijbiomac.2020.06.265","volume":"163","author":"de Campos Vidal B.","year":"2020","unstructured":"de Campos Vidal B.; Mello M.L.; Sodium valproate (VPA) interactions with DNA and histones. Int J Biol Macromol 2020,163,219-231","journal-title":"Int J Biol Macromol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"62","DOI":"10.25824\/redu\/XPTX4F","volume":"201535","author":"Rocha M.A.","unstructured":"Rocha M.A.; Oliveira C.B.; Mello M.L.; Sodium valproate cytotoxicity effects as assessed by the MTT assay. Reposit Rese Data Unicamp ,201535(1),62-65","journal-title":"Reposit Rese Data Unicamp"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nprot.2007.202","volume":"2","author":"Shechter D.","year":"2007","unstructured":"Shechter D.; Dormann H.L.; Allis C.D.; Hake S.B.; Extraction, purification and analysis of histones. Nat Protoc 2007,2(6),1445-1457","journal-title":"Nat Protoc"},{"key":"ref=63","first-page":"3399","author":"Fabian H.","year":"2002","unstructured":"Fabian H.; M&#xE4;ntele W.; Infrared spectroscopy of proteinsHandbook of Vibrational Spectroscop0++yWiley: Chichester 2002,3399-3425","journal-title":"Infrared spectroscopy of proteinsHandbook of Vibrational Spectroscop0++yWiley: Chichester"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.acthis.2014.08.007","volume":"116","author":"Vidal B.C.","year":"2014","unstructured":"Vidal B.C.; Fluorescence, aggregation properties and FT-IR microspectroscopy of elastin and collagen fibers. Acta Histochem 2014,116(8),1359-1366","journal-title":"Acta Histochem"},{"key":"ref=65","author":"Pavia D.L.","year":"2009","unstructured":"Pavia D.L.; Lampman G.M.; Kriz G.S.; Vyvyan J.R.; Introduction to Spectroscopy 2009","journal-title":"Introduction to Spectroscopy"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1134\/S1990519X14040087","volume":"8","author":"Polyanichko A.M.","year":"2014","unstructured":"Polyanichko A.M.; Romanov N.M.; Starkova T.Y.; Kostyleva E.I.; Chikhirzhina E.V.; Analysis of the secondary structure of linker histone H1 based on IR absorption spectra. Cell Tissue Biol 2014,8(4),352-358","journal-title":"Cell Tissue Biol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.micron.2010.09.010","volume":"42","author":"Vidal B.C.","year":"2011","unstructured":"Vidal B.C.; Mello M.L.; Collagen type I amide I band infrared spectroscopy. Micron 2011,42(3),283-289","journal-title":"Micron"},{"key":"ref=68","first-page":"232","volume":"102","author":"Singh B.","year":"2012","unstructured":"Singh B.; Gautam R.; Kumar S.; Kumar Bn V.; Nongthomba U.; Nandi D.; Mukherjee G.; Santosh V.; Somasundaram K.; Umapathy S.; Application of vibrational microspectroscopy to biology and medicine. Curr Sci 2012,102,232-244","journal-title":"Curr Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.bbagen.2011.06.010","volume":"1810","author":"Zelig U.","year":"2011","unstructured":"Zelig U.; Mordechai S.; Shubinsky G.; Sahu R.K.; Huleihel M.; Leibovitz E.; Nathan I.; Kapelushnik J.; Pre-screening and follow-up of childhood acute leukemia using biochemical infrared analysis of peripheral blood mononuclear cells. Biochim Biophys Acta 2011,1810(9),827-835","journal-title":"Biochim Biophys Acta"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/cmdc.200800112","volume":"3","author":"Petru\u0161evski G.","year":"2008","unstructured":"Petru\u0161evski G.; Naumov P.; Jovanovski G.; Bogoeva-Gaceva G.; Ng S.W.; Solid-state forms of sodium valproate, active component of the anticonvulsant drug epilim. ChemMedChem 2008,3(9),1377-1386","journal-title":"ChemMedChem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","volume":"19","author":"Bradbury C.A.","year":"2005","unstructured":"Bradbury C.A.; Khanim F.L.; Hayden R.; Bunce C.M.; White D.A.; Drayson M.T.; Craddock C.; Turner B.M.; Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 2005,19(10),1751-1759","journal-title":"Leukemia"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10549-011-1480-8","volume":"131","author":"Huang Y.","year":"2012","unstructured":"Huang Y.; Vasilatos S.N.; Boric L.; Shaw P.G.; Davidson N.E.; Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells. Breast Cancer Res Treat 2012,131(3),777-789","journal-title":"Breast Cancer Res Treat"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1159\/000438515","volume":"37","author":"Huang Y.","year":"2015","unstructured":"Huang Y.; Yuan L.; Li T.; Wang A.; Li Z.; Pang D.; Wang B.; Ouyang H.; Valproic acid improves porcine parthenogenetic embryo development through transient remodeling of histone modifiers. Cell Physiol Biochem 2015,37(4),1463-1473","journal-title":"Cell Physiol Biochem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/nmat3777","volume":"12","author":"Downing T.L.","year":"2013","unstructured":"Downing T.L.; Soto J.; Morez C.; Houssin T.; Fritz A.; Yuan F.; Chu J.; Patel S.; Schaffer D.V.; Li S.; Biophysical regulation of epigenetic state and cell reprogramming. Nat Mater 2013,12(12),1154-1162","journal-title":"Nat Mater"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"e600","DOI":"10.1038\/tp.2015.90","volume":"5","author":"Lee R.S.","year":"2015","unstructured":"Lee R.S.; Pirooznia M.; Guintivano J.; Ly M.; Ewald E.R.; Tamashiro K.L.; Gould T.D.; Moran T.H.; Potash J.B.; Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene. Transl Psychiatry 2015,5(7),e600","journal-title":"Transl Psychiatry"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.immuni.2014.11.001","volume":"41","author":"Russ B.E.","year":"2014","unstructured":"Russ B.E.; Olshanksy M.; Smallwood H.S.; Li J.; Alice E.; Prier J.E.; Stock A.T.; Croom H.A.; Cullen J.G.; Nguyen M.L.; Rowe S.; Olson M.R.; Finkelstein D.B.; Kelso A.; Thomas P.G.; Speed T.P.; Rao S.; Turner S.J.; Mapping histone methylation dynamics during virus-specific CD8+ T cell differentiation in response to infection. Immunity 2014,41,853-865","journal-title":"Immunity"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/35055010","volume":"3","author":"Taddei A.","year":"2001","unstructured":"Taddei A.; Maison C.; Roche D.; Almouzni G.; Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat Cell Biol 2001,3(2),114-120","journal-title":"Nat Cell Biol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1242\/jcs.02621","volume":"118","author":"B&#xE1;rtov&#xE1; E.","year":"2005","unstructured":"B&#xE1;rtov&#xE1; E.; Pachern&#xED;k J.; Harnicarov&#xE1; A.; Kovar&#xED;k A.; Kovar&#xED;kov&#xE1; M.; Hofmanov&#xE1; J.; Skaln&#xED;kov&#xE1; M.; Kozubek M.; Kozubek S.; Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. J Cell Sci 2005,118(Pt 21),5035-5046","journal-title":"J Cell Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1101\/gr.5540007","volume":"17","author":"Rada-Iglesias A.","year":"2007","unstructured":"Rada-Iglesias A.; Enroth S.; Ameur A.; Koch C.M.; Clelland G.K.; Respuela-Alonso P.; Wilcox S.; Dovey O.M.; Ellis P.D.; Langford C.F.; Dunham I.; Komorowski J.; Wadelius C.; Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes. Genome Res 2007,17(6),708-719","journal-title":"Genome Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4161\/nucl.26209","volume":"4","author":"Light W.H.","year":"2013","unstructured":"Light W.H.; Brickner J.H.; Nuclear pore proteins regulate chromatin structure and transcriptional memory by a conserved mechanism. Nucleus 2013,4(5),357-360","journal-title":"Nucleus"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1242\/jcs.198424","volume":"130","author":"Fi\u0161erov&#xE1; J.","year":"2017","unstructured":"Fi\u0161erov&#xE1; J.; Efenberkov&#xE1; M.; Sieger T.; Maninov&#xE1; M.; Uhl&#xED;\u0159ov&#xE1;, J.; Hoz&#xE1;k, P. Chromatin organization at the nuclear periphery as revealed by image analysis of structured illumination microscopy data. J Cell Sci 2017,130(12),2066-2077","journal-title":"J Cell Sci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S1097-2765(03)00479-9","volume":"12","author":"Rice J.C.","year":"2003","unstructured":"Rice J.C.; Briggs S.D.; Ueberheide B.; Barber C.M.; Shabanowitz J.; Hunt D.F.; Shinkai Y.; Allis C.D.; Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 2003,12(6),1591-1598","journal-title":"Mol Cell"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1091\/mbc.e04-11-0997","volume":"16","author":"Wu R.","year":"2005","unstructured":"Wu R.; Terry A.V.; Singh P.B.; Gilbert D.M.; Differential subnuclear localization and replication timing of histone H3 lysine 9 methylation states. Mol Biol Cell 2005,16(6),2872-2881","journal-title":"Mol Biol Cell"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1096\/fj.09-140145","volume":"24","author":"Mehedint M.G.","year":"2010","unstructured":"Mehedint M.G.; Niculescu M.D.; Craciunescu C.N.; Zeisel S.H.; Choline deficiency alters global histone methylation and epigenetic marking at the Re1 site of the calbindin 1 gene. FASEB J 2010,24(1),184-195","journal-title":"FASEB J"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/jcp.25343","volume":"231","author":"Felisbino M.B.","year":"2016","unstructured":"Felisbino M.B.; Alves da Costa T.; Gatti M.S.V.; Mello M.L.S.; Differential response of human hepatocyte chromatin to HDAC inhibitors as a function of microenvironmental glucose level. J Cell Physiol 2016,231(10),2257-2265","journal-title":"J Cell Physiol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.stemcr.2017.04.006","volume":"8","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; He X.; Li Q.; Kong X.; Ou Z.; Zhang L.; Gong Z.; Long D.; Li J.; Zhang M.; Ji W.; Zhang W.; Xu L.; Xuan A.; PI3K\/AKT\/mTOR signaling mediates valproic acid-induced neuronal differentiation of neural stem cells through epigenetic modifications. Stem Cell Reports 2017,8(5),1256-1269","journal-title":"Stem Cell Reports"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"Margueron R.","year":"2011","unstructured":"Margueron R.; Reinberg D.; The polycomb complex PRC2 and its mark in life. Nature 2011,469(7330),343-349","journal-title":"Nature"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.tibs.2010.05.006","volume":"35","author":"Barth T.K.","year":"2010","unstructured":"Barth T.K.; Imhof A.; Fast signals and slow marks: The dynamics of histone modifications. Trends Biochem Sci 2010,35(11),618-626","journal-title":"Trends Biochem Sci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.stem.2008.11.011","volume":"4","author":"Cui K.","year":"2009","unstructured":"Cui K.; Zang C.; Roh T.Y.; Schones D.E.; Childs R.W.; Peng W.; Zhao K.; Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 2009,4(1),80-93","journal-title":"Cell Stem Cell"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13072-015-0021-9","volume":"8","author":"Halsall J.A.","year":"2015","unstructured":"Halsall J.A.; Turan N.; Wiersma M.; Turner B.M.; Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response. Epigenetics Chromatin 2015,8(1),29","journal-title":"Epigenetics Chromatin"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"37409","DOI":"10.18632\/oncotarget.16964","volume":"8","author":"Scialdone A.","year":"2017","unstructured":"Scialdone A.; Hasni M.S.; Damm J.K.; Lennartsson A.; Gullberg U.; Drott K.; The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo. Oncotarget 2017,8(23),37409-37422","journal-title":"Oncotarget"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.25824\/redu\/OSK2UP","author":"Mello M.L.","year":"2021","unstructured":"Mello M.L.; Vidal B.C.; Infrared data of sodium valproate (VPA), histones and VPA-histone mixtures 2021","journal-title":"Infrared data of sodium valproate (VPA), histones and VPA-histone mixtures"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1007\/s13277-014-1737-z","volume":"35","author":"Fang J.","year":"2014","unstructured":"Fang J.; Zhang H.; Jin S.; Epigenetics and cervical cancer: From pathogenesis to therapy. Tumour Biol 2014,35(6),5083-5093","journal-title":"Tumour Biol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13072-021-00432-5","volume":"14","author":"Baumann C.","year":"2021","unstructured":"Baumann C.; Zhang X.; Zhu L.; Fan Y.; De La Fuente R.; Changes in chromatin accessibility landscape and histone H3 core acetylation during valproic acid-induced differentiation of embryonic stem cells. 2021,14,58","journal-title":""}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1874467215666220316110405","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/202281\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1874467215666220316110405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:59:06Z","timestamp":1746572346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/202281\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467215666220316110405","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}